Pro Pharmaceuticals Group supports Australian hospitals and pharmaceutical partners with critical medicine access, medicine shortages, TGA Section 19A and SAS pathways, comparator sourcing and global clinical trial supply.

Why do medicines run short? Follow the pharmaceutical supply chain from manufacturing and batch release to the hospital ward, and discover why medicine shortages occur and how alternative supply pathways can help maintain patient access.

Tuberculosis continues to affect over 10 million people each year. In this article, Pro Pharmaceuticals Group explores why equitable access to TB medicines is still critical in 2025 — and how ethical, non-profit supply partnerships can help close the gap.

Behind every successful pharmaceutical delivery is a team of experts ensuring safe, compliant access to critical medicines. Meet the people

When a hospital faced a critical pharmaceutical shortage, Pro Pharmaceuticals Group stepped in to secure urgent access to life-saving med

Ensuring a consistent and secure supply of essential medicines for hospitals and clinical trials goes beyond logistics—it demands precision, expertise, and a deep understanding of regulatory frameworks. At Pro Pharmaceuticals Group, we take a proactive approach to pharmaceutical access, guaranteeing that every shipment meets the highest standards of security, efficiency, and compliance. Our expertise in logistics and regulatory requirements ensures medicines are stored and tr

Pro Pharmaceuticals Group is a trusted partner for hospitals and clinical trials, specializing in secure, expert-led access to hard-to-sourc

If this was written in the USA or European Markets then the title would only be Early Access Program as those markets would be targeted by any Pharmaceutical Company! However many companies may not plan Australia in their global plan or plan Australia at a later stage in their product life cycle. The Australian market is around 25 million population with high global health standards, products in public hospitals are paid for by the hospital budgets and clinical needs of pati

Pro PG team filled in June 2020 a large order for critical ICU medicine needed by our Europe based client in their region. This represents the 3rd large shipment we have completed in the COVID-19 period into 3 different regions. Projects were sucessfully managed by the Pro PG team.

Pro PG team filled a large order for critical ICU medicine needed by our client in their region. This was a considerable large shipment totalling 13 pallets of stock. This represented our 2nd large shipment in the COVID period the same ICU medicine. The Project was successfully managed by Lukasz Nowaczek our Poland based representative who worked closely with our dedicated logistic partner in this challenging COVID-19 period.